Enteropathy-associated T-cell lymphoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
Nima Nasiri (talk | contribs) (Created page with "==Treatment== ===Medical Therapy=== *There is no treatment for enteropathy-associated T-cell lymphoma; the mainstay of therapy is supportive care. The optimal therapy for ente...") |
Nima Nasiri (talk | contribs) No edit summary |
||
| Line 25: | Line 25: | ||
* Drug regimen: (CHOP) [[Cyclophosphamide]] {{and}} [[Doxorubicin]] {{and}} [[Vincristine]] {{and}} [[Prednisone]] | * Drug regimen: (CHOP) [[Cyclophosphamide]] {{and}} [[Doxorubicin]] {{and}} [[Vincristine]] {{and}} [[Prednisone]] | ||
|} | |} | ||
==References== | |||
{{reflist|2}} | |||
Revision as of 19:17, 9 January 2019
Treatment
Medical Therapy
- There is no treatment for enteropathy-associated T-cell lymphoma; the mainstay of therapy is supportive care. The optimal therapy for enteropathy-associated T-cell lymphoma depends on the extent and the location of the lymphoma in the small intestine.[1] Stem cell transplant can be helpful in those patients that are in remission phase of disease.[2]
| Therapy | Description |
|---|---|
| Supportive therapy |
|
| Surgery |
|
| Chemotherapy |
|
References
- ↑ 1.0 1.1 Enteropathy-associated T-cell lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/enteropathy-associated-t-cell-lymphoma/?region=on Accessed on January 26, 2016
- ↑ Rongey C, Micallef I, Smyrk T, Murray J (June 2006). "Successful treatment of enteropathy-associated T cell lymphoma with autologous stem cell transplant". Dig. Dis. Sci. 51 (6): 1082–6. doi:10.1007/s10620-006-8013-z. PMID 16865575.